SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-08-027707
Filing Date
2008-12-12
Accepted
2008-12-12 14:58:09
Documents
1
Period of Report
2008-02-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 7445
  Complete submission text file 0001140361-08-027707.txt   9546
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-227
Business Address 18 AVENUE DE LA PORTE NEUVE LUXEMBOURG N4 L-227 650-470-4500
Inverlochy Consultadoria & Servicos L.D.A. (Reporting) CIK: 0001384386 (see all company filings)

State of Incorp.: S1 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-15070 | Film No.: 081246396